FGFR2 and infantile convulsions and choreoathetosis: In a recent phase 2 study, 103 patients stratified for their unresectable or metastatic FGFR2 fusion-positive or FGFR2 rearrangement-positive iCCA were enrolled and treated with Futibatinib [143].